切换至 "中华医学电子期刊资源库"

中华胃肠内镜电子杂志 ›› 2019, Vol. 06 ›› Issue (03) : 121 -124. doi: 10.3877/cma.j.issn.2095-7157.2019.03.006

所属专题: 专题评论 文献

综述

进展期结直肠癌新辅助治疗疗效评价方法的研究进展
詹红丽1, 王蓉1, 王雯1,()   
  1. 1. 350025 福建 福州,联勤保障部队第九〇〇医院消化内科,福建医科大学福总临床医学院,厦门大学附属东方医院
  • 收稿日期:2019-08-02 出版日期:2019-08-15
  • 通信作者: 王雯
  • 基金资助:
    福建省社会发展引导性(重点)项目(2018Y0066)

Advances in study on evaluation methods of neoadjuvant therapy for advanced colorectal cancer

Hongli Zhan1, Rong Wang1, Wen Wang1,()   

  1. 1. Department of Gastroenterology, 900 Hospital of the Joint Logistics Team, Fuzong Clinical Medical College of Fujian Medical University, Eastern Hospital Affiliated to Xiamen University, Fuzhou 350025, China
  • Received:2019-08-02 Published:2019-08-15
  • Corresponding author: Wen Wang
  • About author:
    Corresponding author: Wang Wen, Email:
引用本文:

詹红丽, 王蓉, 王雯. 进展期结直肠癌新辅助治疗疗效评价方法的研究进展[J]. 中华胃肠内镜电子杂志, 2019, 06(03): 121-124.

Hongli Zhan, Rong Wang, Wen Wang. Advances in study on evaluation methods of neoadjuvant therapy for advanced colorectal cancer[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2019, 06(03): 121-124.

新辅助治疗可使原发肿瘤或转移病灶缩小,降低肿瘤分期,已被认为是进展期结直肠癌(ACRC)的主要治疗方式。但由于肠道为空腔脏器,原发病灶准确测量困难,新辅助治疗后的疗效评估更加困难。因此,就结直肠癌而言,目前缺乏统一的、有针对性的、效果明显的评价系统和标准。本文就ACRC新辅助治疗目前疗效评价方法做一综述。

The primary or metastatic tumor, even the tumor stage may be reduced after neoadjuvant therapy, and it has been considered as the main treatment for advanced colorectal cancer(ACRC). However, the accurate measurement of the primary lesion in hollow organ, such as the intestine, is difficult, so as the evaluation of the therapeutic effect after neoadjuvant therapy.Therefore, there is no unified, targeted, and effective evaluation systems and standards for colorectal cancer, and this article reviews the current efficacy evaluation methods of ACRC neoadjuvant therapy.

[1]
Wong PK, Berry S, Spithorff K,et al.Preoperative or postoperative therapy for stageⅡrectal cancer:updated practice guideline[J].Clin Oncol(R Coil Radial),2010,22(4): 265-271.
[2]
Rolf Sauer, Heinz Becker, Werner Hohenberger,et al.Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer[J].N Engl J Med, 2004,351: 1731-1740.
[3]
Sun Z, Adam MA, Kim J,et al.Association Between Neoadjuvant Chemoradiation and Survival for Patients With Locally Advanced Rectal Cancer[J].Colorectal Dis, 2017, 19(12): 1058-1066.
[4]
Benson AB, Venook AP, Al-Hawary MM, et al. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology [J].J Natl Compr Canc Netw,2018,16(7): 874-901.
[5]
Martin EW, Minton JP, Carey LC.CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma[J].Ann Surg,1985,202(3): 310-317.
[6]
Nicholson BD, Shinkins B, Pathiraja I,et al.Blood CEA levels for detecting recurrent colorectal cancer[J]. Cochrane Database Syst Rev,2015,10(12): CD011134.
[7]
彭俊杰,朱骥,刘方奇,等.中国局部进展期直肠癌诊疗专家共识[J].中国癌症杂志,2017,27(1): 41-80.
[8]
Bipat S, Glas AS, Slors FJ,et al.Rectal cancer:local staging and assessment of lymph node involvement with endoluminal US,CT,and MR imaging-a meta-analysis[J].Radiology,2004,232(3): 773-783.
[9]
Taylor FG, Quirke P, Heald RJ,et al.One millimeter is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer[J].Br J Surg,2011, 98(6): 872-879.
[10]
Smith NJ, Barbachano Y, Norman AR,et al.Prognostic significance of magnetic resonance imagingdetected extramural vascular invasion in rectal cancer[J].Br J Surg,2008, 95(2): 229-236.
[11]
Barbaro B, Fiorucci C, Tebala C,et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy[J].Radiology, 2009,250(3): 730-839.
[12]
Hanly AM, Ryan EM, Rogers AC,et al.Multicenter Evaluation of Rectal cancer ReImaging post Neoadjuvant (MERRION) Therapy[J]. Ann Surg, 2014, 259(4): 723.
[13]
肖晓娟,余深平,李子平,等.MR灌注成像在结直肠癌中的应用现状[J].国际医学放射学杂志,2015,(2): 138-142.
[14]
Kim SH, Lee JM, Hong SH,et al.Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy[J]. Radiology,2009,253(1): 116-125.
[15]
Wu LM, Zhu J, Hu J,et al.Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer? [J].Int J Colorectal Dis,2013,28(9): 1225-1238.
[16]
Heye T, Kuntz C, Düx M,et al.CT and endoscopic ultrasound in comparison to endoluminal MRI: preliminary results in staging gastric carcinoma[J].Eur J Radiol,2009,70(2): 336-341.
[17]
Zlobec I.Assessing downgrading of locally advanced rectal cancer after chemo-radiotherapy[J].Eur J Cancer, 2011,47(8): 1125-1126.
[18]
Ryan R, Gibbons D, Hyland J M P,et al.Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer[J]. Histopathology, 2005, 47(2): 141-146.
[19]
Dede K, Salamon F, Landherr L,et al.Pathologic assessment of response to chemotherapy in colorectal cancer liver metastases after hepatic resection: which method to use?[J]. Pathol Oncol Res,2015, 21(1): 173-179.
[20]
Tie J, Kinde I, Wang Y,et al.Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer[J]. Ann Oncol,2015,26(8): 1715-1722.
[21]
Bettegowda C, Sausen M, Leary RJ,et al.Detection of circulating tumor DNA in early- and late-stage human malignancies[J].Sci Transl Med,2014,6(224): 224ra24.
[22]
Magni E, Botteri E, Ravenda P S,et al.Detection of circulating tumor cells in patients with locally advanced rectal cancer undergoing neoadjuvant therapy followed by curative surgery[J].Int J Colorectal Dis,2014, 29(9): 1053-1059.
[23]
Han HJ, Russo J, Kohwi Y,et al. SATC reprogrammes gene expression to promote breast tumour growth and metastasis[J].Nature,2008,452(7184): 187-193.
[24]
Lu X, Cheng C, Zhu S,et al. SATC is an independent prognostic marker for gastric cancer in a Chinese population[J]. Oncol Rep,2010,24(4): 981-987.
[25]
Cheng C, Lu X, Wang G,et al.Expression of SATC and heparanase in gastric cancer and its relationship to clinicopathologic features[J]. APMIS,2010,118(11): 855-863.
[26]
Tu W, Luo M, Wang Z,et al.Upregulation of SATC promotes tumor growth and metastasis in liver cancer[J]. Liver Int, 2012,32(7): 1064-1078.
[27]
Meng WJ, Pathak S, Ding ZY, et al.Special AT-rich sequence binding protein 1 expression correlates with response to preoperative radiotherapy and clinical outcome in rectal cancer[J].Cancer Biol Ther,2015, 16(12): 1738-1745.
[28]
Sargent DJ, Marsoni S, Monges G,et al.Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer[J]. J Clin Oncol,2010,28(20): 3219-3226.
[1] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[2] 王亚萍, 樊菁, 侯牛牛, 凌瑞. 肿瘤浸润性淋巴细胞在HER-2阳性早期乳腺癌中的临床意义[J]. 中华乳腺病杂志(电子版), 2023, 17(04): 203-209.
[3] 何传超, 肖治宇. 晚期肝癌综合治疗模式与策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 486-489.
[4] 邹敏, 徐明, 吴伟强, 归明彬, 高峰. 低位直肠癌新辅助放化疗应用的焦点问题[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 363-371.
[5] 陈润芝, 杨东梅, 徐慧婷. 信迪利单抗联合索凡替尼后线治疗MSS型BRAF突变的转移性结肠癌:个案报道并文献复习[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 431-435.
[6] 鄂一民, 孙司正, 范小彧, 喻春钊. 结直肠癌粪便筛查的现状与展望[J]. 中华结直肠疾病电子杂志, 2023, 12(04): 331-336.
[7] 梁文龙, 曹杰, 黄庆, 林泳, 黄红丽, 杨平, 李冠炜, 胡鹤. 信迪利单抗联合瑞戈非尼治疗晚期结直肠癌的疗效与安全性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 409-413.
[8] 王小娜, 谭微, 李悦, 姜文艳. 预测性护理对结直肠癌根治术患者围手术期生活质量、情绪及并发症的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 525-529.
[9] 刘代江, 蒋俊艳, 万晓强, 马莎英. 结直肠癌肝转移患者生存状况及预后影响因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 284-288.
[10] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[11] 王飞飞, 王光林, 孟泽松, 李保坤, 曹龙飞, 张娟, 周超熙, 丁源一, 王贵英. 敲低IMPDH1对结肠癌SW480、HT29细胞生物功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(08): 884-890.
[12] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[13] 孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.
[14] 王亚丹, 吴静, 黄博洋, 王苗苗, 郭春梅, 宿慧, 王沧海, 王静, 丁鹏鹏, 刘红. 白光内镜下结直肠肿瘤性质预测模型的构建与验证[J]. 中华临床医师杂志(电子版), 2023, 17(06): 655-661.
[15] 王延召, 牛鹏飞, 丁长民, 高庆坤, 高兆亚, 安柯, 翟志超, 曾庆敏, 黄文生, 雷福明, 顾晋. 结直肠癌致腹壁巨大缺损的一期修补经验(附13例报告)[J]. 中华临床医师杂志(电子版), 2023, 17(05): 557-561.
阅读次数
全文


摘要